With anxiety about the U.S. drug supply running high these days, drugmakers have been keeping a close eye on demand spikes. Now, Johnson & Johnson, maker of...

As of this morning - Wednesday April 2 - the current recorded case count for COVID-19 (coronavirus) in the UK has hit 29,474, with 2,352 deaths. Gilead Sciences ha...

Mind Medicine Inc., a New York-based psychedelic drug development company, that counts Shark Tank star Kevin O’Leary and Toms Shoes founder Blake Mycoskie as investo...

Following the selection of a COVID-19 vaccine lead, Johnson & Johnson (J&J) aims to begin clinical trials in humans later this year while also scaling up its...

Vaccine nears marketing authorisation approval in Europe Maidenhead, 1 April 2020              &nb...

The FDA suspended a drug import ban on India’s troubled Ipca to unleash its large capacity for a drug that might help against COVID-19 but the agency’s largesse may ...

Gilead Sciences' investigational antiviral drug remdesivir has been saddled with high hopes as drugmakers search for a possible COVID-19 treatment. But after th...

Last month, Novartis got a leg up in its race against Merck KGaA to bring rival targeted lung cancer drugs to market in the U.S. But in Japan, it’s the German drugma...

Clinerion has gained ISO 27001:2013 certification, the international standard that describes best practice for an information security management system (ISMS). IS...

The U.S. Food and Drug Administration today issued a guidance for industry, investigators and institutional review boards conducting clinical trials during the coron...